Journal
SCIENCE OF THE TOTAL ENVIRONMENT
Volume 744, Issue -, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.scitotenv.2020.140954
Keywords
Nanofiltration; Micropollutants rejections; Environmental risks; Wastewater reclamation; Engineering application
Categories
Funding
- Major Water Project of China [2017ZX07103]
- National Key R&D Program of China [2016YFE0118800]
- Natural Science Foundation of China [51761125013]
Ask authors/readers for more resources
The emerging contaminants, in particular pharmaceuticals and personal care products and environmental estrogens, have been received global concerns in recent years. Nanofiltration (NF) as an advanced tertiary treatment technology can be a reliable and potential tool for micropollutants removal. However, the influence of operation conditions of NF system to micropollutants rejections in an engineering application, is still lacking. Here, a pilotscale NF system was set up to investigate its removal efficiencies to 49 micropollutants under different operation conditions by treating actual municipal wastewater. The results showed that the rejections of positively and neutrally charged micropollutants with molecular weight higher than 250 g mol(-1) were both higher than 80%. Besides, most negatively charged micropollutants were also rejected higher than 80% under different operation conditions. The rejections of most micropollutants increased with temperature decreased from 25 degrees C to 13 degrees C, which was primarily ascribed to decrease of pore size of NF membrane at low temperature. Compared with the water recovery rate of 80%, lower rejections of micropollutants were observed with lower water recovery rate of 60%. Except for sulfamethoxazole, the risk quotients of other detected 20 micropollutants in NF effluent were all lower than 1.0, showing medium or no risks to aquatic organisms. This study might aid understanding the performance of micropollutants rejections by NF in actual engineering application and could give guideline to the implementation of NF technology in future advanced treatment processes. (C) 2020 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available